These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

668 related articles for article (PubMed ID: 26919248)

  • 1. Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice.
    Taverna S; Giallombardo M; Gil-Bazo I; Carreca AP; Castiglia M; Chacártegui J; Araujo A; Alessandro R; Pauwels P; Peeters M; Rolfo C
    Oncotarget; 2016 May; 7(19):28748-60. PubMed ID: 26919248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients.
    Li C; Li C; Zhi C; Liang W; Wang X; Chen X; Lv T; Shen Q; Song Y; Lin D; Liu H
    J Transl Med; 2019 Oct; 17(1):355. PubMed ID: 31665020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer.
    Xia J; Luo M; Dai L; Wang L; Wang L; Zhu J
    J Clin Lab Anal; 2021 May; 35(5):e23743. PubMed ID: 33682961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum exosomal miR-378 upregulation is associated with poor prognosis in non-small-cell lung cancer patients.
    Zhang Y; Xu H
    J Clin Lab Anal; 2020 Jun; 34(6):e23237. PubMed ID: 32061007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in
    Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q
    J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a novel linc01125 isoform in serum exosomes as a promising biomarker for NSCLC diagnosis and survival assessment.
    Xian J; Zeng Y; Chen S; Lu L; Liu L; Chen J; Rao B; Zhao Z; Liu J; Xie C; Zhu L; Zhang D; Qiu F; Lu J; Yang L
    Carcinogenesis; 2021 Jun; 42(6):831-841. PubMed ID: 33928340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating serum exosomal miR-20b-5p and miR-3187-5p as efficient diagnostic biomarkers for early-stage non-small cell lung cancer.
    Zhang ZJ; Song XG; Xie L; Wang KY; Tang YY; Yu M; Feng XD; Song XR
    Exp Biol Med (Maywood); 2020 Oct; 245(16):1428-1436. PubMed ID: 32741216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patients.
    Janpipatkul K; Trachu N; Watcharenwong P; Panvongsa W; Worakitchanon W; Metheetrairut C; Oranratnachai S; Reungwetwattana T; Chairoungdua A
    Cancer Biomark; 2021; 31(3):281-294. PubMed ID: 33896827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer.
    Yang XR; Pi C; Yu R; Fan XJ; Peng XX; Zhang XC; Chen ZH; Wu X; Shao Y; Wu YL; Zhou Q
    Clin Exp Metastasis; 2021 Feb; 38(1):109-117. PubMed ID: 33231826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-let-7e in serum-derived exosomes inhibits the metastasis of non-small-cell lung cancer in a SUV39H2/LSD1/CDH1-dependent manner.
    Xu S; Zheng L; Kang L; Xu H; Gao L
    Cancer Gene Ther; 2021 Apr; 28(3-4):250-264. PubMed ID: 33299140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4.
    Kim DH; Park S; Kim H; Choi YJ; Kim SY; Sung KJ; Sung YH; Choi CM; Yun M; Yi YS; Lee CW; Kim SY; Lee JC; Rho JK
    Cancer Lett; 2020 Apr; 475():2-13. PubMed ID: 32004570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal miRNA Analysis in Non-small Cell Lung Cancer (NSCLC) Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool.
    Giallombardo M; Chacártegui Borrás J; Castiglia M; Van Der Steen N; Mertens I; Pauwels P; Peeters M; Rolfo C
    J Vis Exp; 2016 May; (111):. PubMed ID: 27285610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue and exosomal miRNA editing in Non-Small Cell Lung Cancer.
    Nigita G; Distefano R; Veneziano D; Romano G; Rahman M; Wang K; Pass H; Croce CM; Acunzo M; Nana-Sinkam P
    Sci Rep; 2018 Jul; 8(1):10222. PubMed ID: 29976955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression.
    Grimolizzi F; Monaco F; Leoni F; Bracci M; Staffolani S; Bersaglieri C; Gaetani S; Valentino M; Amati M; Rubini C; Saccucci F; Neuzil J; Tomasetti M; Santarelli L
    Sci Rep; 2017 Nov; 7(1):15277. PubMed ID: 29127370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration of Serum Exosomal LncRNA TBILA and AGAP2-AS1 as Promising Biomarkers for Diagnosis of Non-Small Cell Lung Cancer.
    Tao Y; Tang Y; Yang Z; Wu F; Wang L; Yang L; Lei L; Jing Y; Jiang X; Jin H; Bai Y; Zhang L
    Int J Biol Sci; 2020; 16(3):471-482. PubMed ID: 32015683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.
    Tian W; Yang X; Yang H; Lv M; Sun X; Zhou B
    Cell Death Dis; 2021 Oct; 12(11):1030. PubMed ID: 34718336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum long non coding RNA MALAT-1 protected by exosomes is up-regulated and promotes cell proliferation and migration in non-small cell lung cancer.
    Zhang R; Xia Y; Wang Z; Zheng J; Chen Y; Li X; Wang Y; Ming H
    Biochem Biophys Res Commun; 2017 Aug; 490(2):406-414. PubMed ID: 28623135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Potential Biomarkers and Immunological Effects of Tumor-Derived Exosomes in Lung Cancer.
    Alipoor SD; Mortaz E; Varahram M; Movassaghi M; Kraneveld AD; Garssen J; Adcock IM
    Front Immunol; 2018; 9():819. PubMed ID: 29720982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancer.
    Gao J; Qiu X; Li X; Fan H; Zhang F; Lv T; Song Y
    Biochem Biophys Res Commun; 2018 Apr; 498(3):409-415. PubMed ID: 29452091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.